本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Edgewise Therapeutics, Inc.

32.82
-0.7000-2.09%
盤後32.820.00000.00%18:22 EDT
成交量:59.93萬
成交額:1,967.91萬
市值:35.21億
市盈率:-20.13
高:33.72
開:33.52
低:32.26
收:33.52
52周最高:34.00
52周最低:11.23
股本:1.07億
流通股本:6,084.98萬
量比:0.85
換手率:0.98%
股息:- -
股息率:- -
每股收益(TTM):-1.6302
每股收益(LYR):-1.6302
淨資產收益率:-34.19%
總資產收益率:-23.02%
市淨率:6.74
市盈率(LYR):-20.13

資料載入中...

2025/04/02

重要事件披露

Form 8-K - Current report
2025/03/04

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/03

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/03

重要事件披露

Form 8-K - Current report
2025/02/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/22

重要事件披露

Form 8-K - Current report
2024/12/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/16

重要事件披露

Form 8-K - Current report
2024/11/14

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/07

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/11/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/07

重要事件披露

Form 8-K - Current report